These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 24147758)
1. Potential impact of combined high- and low-risk human papillomavirus infection on the progression of cervical intraepithelial neoplasia 2. Okadome M; Saito T; Tanaka H; Nogawa T; Furuta R; Watanabe K; Kita T; Yamamoto K; Mikami M; Takizawa K; J Obstet Gynaecol Res; 2014 Feb; 40(2):561-9. PubMed ID: 24147758 [TBL] [Abstract][Full Text] [Related]
2. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status]. Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846 [No Abstract] [Full Text] [Related]
3. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds. C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804 [TBL] [Abstract][Full Text] [Related]
4. Distribution and diagnostic value of single and multiple high-risk HPV infections in detection of cervical intraepithelial neoplasia: A retrospective multicenter study in China. Ye Z; Zhao Y; Chen M; Lu Q; Wang J; Cui X; Wang H; Xue P; Jiang Y J Med Virol; 2024 Aug; 96(8):e29835. PubMed ID: 39087721 [TBL] [Abstract][Full Text] [Related]
5. PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort. Kang Y; Sun P; Mao X; Dong B; Ruan G; Chen L J Gynecol Oncol; 2019 May; 30(3):e29. PubMed ID: 30887754 [TBL] [Abstract][Full Text] [Related]
6. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation. Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225 [TBL] [Abstract][Full Text] [Related]
7. Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology. Stoler MH; Wright TC; Parvu V; Yanson K; Cooper CK; Andrews J Gynecol Oncol; 2019 Apr; 153(1):26-33. PubMed ID: 30638767 [TBL] [Abstract][Full Text] [Related]
8. The impact of human papillomavirus type on colposcopy performance in women offered HPV immunisation in a catch-up vaccine programme: a two-centre observational study. Munro A; Gillespie C; Cotton S; Busby-Earle C; Kavanagh K; Cuschieri K; Cubie H; Robertson C; Smart L; Pollock K; Moore C; Palmer T; Cruickshank ME BJOG; 2017 Aug; 124(9):1394-1401. PubMed ID: 28102931 [TBL] [Abstract][Full Text] [Related]
9. Predictor factors for conservative management of cervical intraepithelial neoplasia grade 2: Cytology and HPV genotyping. Salvadó A; Miralpeix E; Solé-Sedeno JM; Kanjou N; Lloveras B; Duran X; Mancebo G Gynecol Oncol; 2021 Sep; 162(3):569-574. PubMed ID: 34226019 [TBL] [Abstract][Full Text] [Related]
10. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia. Almog B; Gamzu R; Kuperminc MJ; Levin I; Fainaru O; Niv J; Bar-Am A Gynecol Oncol; 2003 Mar; 88(3):345-50. PubMed ID: 12648585 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China. Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906 [TBL] [Abstract][Full Text] [Related]
12. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination. Song F; Yan P; Huang X; Wang C; Du H; Qu X; Wu R BMC Cancer; 2022 Jan; 22(1):42. PubMed ID: 34991494 [TBL] [Abstract][Full Text] [Related]
13. Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study. Fröberg M; Östensson E; Belkić K; Oštrbenk A; Poljak M; Mints M; Arbyn M; Andersson S Cancer; 2019 Jan; 125(2):239-248. PubMed ID: 30536370 [TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of high-grade cervical intraepithelial neoplasia during pregnancy: A 10-year experience. Hong DK; Kim SA; Lim KT; Lee KH; Kim TJ; So KA Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():173-176. PubMed ID: 30933887 [TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of the Amplicor HPV test for predicting progression of cervical intraepithelial neoplasia 2. Nogawa T; Hiura M; Tanaka H; Saito T; Furuta R; Watanabe K; Kita T; Yamamoto K; Mikami M; Takizawa K; J Obstet Gynaecol Res; 2013 Aug; 39(8):1347-53. PubMed ID: 23815550 [TBL] [Abstract][Full Text] [Related]
16. Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression. Liu S; Minaguchi T; Lachkar B; Zhang S; Xu C; Tenjimbayashi Y; Shikama A; Tasaka N; Akiyama A; Sakurai M; Nakao S; Ochi H; Onuki M; Matsumoto K; Yoshikawa H; Satoh T PLoS One; 2018; 13(2):e0193061. PubMed ID: 29466435 [TBL] [Abstract][Full Text] [Related]
17. Identification of vaccine human papillomavirus genotypes in squamous intraepithelial lesions (CIN2-3). González-Bosquet E; Esteva C; Muñoz-Almagro C; Ferrer P; Pérez M; Lailla JM Gynecol Oncol; 2008 Oct; 111(1):9-12. PubMed ID: 18684497 [TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus test with cytology triage in organized screening for cervical cancer. Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407 [TBL] [Abstract][Full Text] [Related]
19. Effects of exposure to polycyclic aromatic hydrocarbons combined with high-risk human papillomavirus infection on cervical intraepithelial neoplasia: A population study in Shanxi Province, China. Li X; Ding L; Song L; Gao W; Wang L; Wang J Int J Cancer; 2020 May; 146(9):2406-2412. PubMed ID: 31290154 [TBL] [Abstract][Full Text] [Related]
20. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]